Hisamitsu Pharmaceuticals

Silver Sponsor

Hisamitsu Pharmaceutical is operating in more than 10 countries and regions around the world by developing, manufacturing and marketing pharmaceutical products. Utilizing the basic technology platform of TDDS (Transdermal Drug Delivery System), including both patch and microneedle platforms. Our microneedle platform, HalDisc technology have various potential benefits for vaccine products in terms of efficacy, safety and storage stability. In addition to TDDS formulation, we will run a wide range of businesses with various products and services based on the technology developed over the years to deliver a better QOL (Quality of Life) to the world.